Get the Stockscreener App
2.46
1.60%
-0.04
Strata Skin Sciences Inc stock is traded at $2.46, with a volume of 11,635.
It is down -1.60% in the last 24 hours and down -8.21% over the past month.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.
See More
Previous Close:
$2.50
Open:
$2.49
24h Volume:
11,635
Relative Volume:
2.34
Market Cap:
$10.97M
Revenue:
$33.36M
Net Income/Loss:
$-10.83M
P/E Ratio:
-7.9355
EPS:
-0.31
Net Cash Flow:
$-5.54M
1W Performance:
-6.46%
1M Performance:
-8.21%
6M Performance:
-20.44%
1Y Performance:
-35.43%
1-Day Range:
$2.33
$2.81
1-Week Range:
$2.10
$2.88
52-Week Range:
$2.10
$4.70
Strata Skin Sciences Inc Stock (SSKN) Company Profile
Name
Strata Skin Sciences Inc
Sector
Industry
Phone
215-619-3200
Address
5 WALNUT GROVE DRIVE, HORSHAM, PA
Compare SSKN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SSKN
Strata Skin Sciences Inc
|
2.46 | 10.97M | 33.36M | -10.83M | -5.54M | -0.31 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Strata Skin Sciences Inc Stock (SSKN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-19 | Initiated | Ladenburg Thalmann | Buy |
| Nov-21-19 | Initiated | Oppenheimer | Outperform |
| Dec-10-18 | Initiated | Northland Capital | Outperform |
| May-16-17 | Reiterated | Rodman & Renshaw | Buy |
| Feb-21-17 | Resumed | Rodman & Renshaw | Buy |
Strata Skin Sciences Inc Stock (SSKN) Latest News
STRATA Skin Sciences to Participate in the D. Boral Capital Inaugural Global Conference - GlobeNewswire
Strata Skin Sciences To Report First Quarter 2025 Financial Results On May 14, 2025 And Provide Corporate Update - marketscreener.com
STRATA Skin Sciences, Inc. to Report First Quarter 2025 Financial Results on May 14, 2025 - Nasdaq
STRATA Skin Sciences to Report First Quarter 2025 Financial Results on May 14, 2025 and Provide Corporate Update - GlobeNewswire
Press Release Distribution & PR Platform - ACCESS Newswire
Facial Rejuvenation Market Report 2025-2034: Industry - openPR.com
Aesthetic Lasers Market Is Booming So Rapidly | Lumenis, Viora, Sciton - openPR.com
Dermatology Excimer Laser Market Size to Hit USD 1,725.35 Million by 2034 - Precedence Research
Study Validates Advantages of STRATA Skin Sciences’ XTRAC Laser Technology - MSN
The Evolution of Dermatology Devices Market: What to Expect in 2025 - WhaTech
Dermatology Excimer Laser Market Size & Share Report, 2034 - Global Market Insights Inc.
STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q4 2024 Earnings Call Transcript - MSN
STRATA Skin Sciences Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
STRATA Skin Sciences revenue up 10% to USD 9.6 million in Q4 2024 - Medical Buyer
STRATA Skin Sciences Reports Strong Q4 Growth and Strategic Progress - MSN
Strata Skin Sciences Inc. (SSKN) reports earnings - Quartz
STRATA Skin Sciences Reports Growth Amid Strategic Shifts - TipRanks
Strata Skin Sciences Reports Q4 2024 Financial Results - TipRanks
Earnings call transcript: STRATA Skin Sciences Q4 2024 revenue rises 10% By Investing.com - Investing.com South Africa
Earnings call transcript: STRATA Skin Sciences Q4 2024 revenue rises 10% - Investing.com India
STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Corporate Update - GlobeNewswire
STRATA Skin Sciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView
STRATA SKIN SCIENCES Earnings Results: $SSKN Reports Quarterly Earnings - Nasdaq
Earnings Preview For Strata Skin Sciences - Benzinga
STRATA Skin Sciences Inc expected to post a loss of 30 cents a shareEarnings Preview - TradingView
STRATA SKIN SCIENCES Earnings Preview: Recent $SSKN Insider Trading, Hedge Fund Activity, and More - Nasdaq
STRATA Skin Sciences to Announce Year-End Financial Results - MSN
STRATA Skin Sciences to Report Fourth Quarter and Year End 2024 Financial Results on March 27, 2025 and Provide Corporate Update - The Manila Times
STRATA Skin Sciences to Report Fourth Quarter and Year End - GlobeNewswire
STRATA Skin Sciences: Unveiling Q4 2024 Financials and Corporate Strategy - AInvest
STRATA Skin Sciences, Inc. to Report Fourth Quarter and Year End 2024 Financial Results on March 27, 2025 - Nasdaq
STRATA Skin Sciences Year-End Earnings and Strategic Update: Key Details for Investors - StockTitan
Excimer laser outperforms in dermatologic study - Investing.com India
Strata Skin Sciences Highlights XTRAC® Laser Study Success - TipRanks
Identity, Access Management & Biometric Solutions Provider BIO-key International Hosts Q4 Investor Call Thursday, March 27th at 10am ET - The Manila Times
STRATA Skin Sciences Highlights Study Validating Superior Efficacy of XTRAC® Excimer Laser Technology for Dermatologic Treatments - Nasdaq
STRATA Skin Sciences Highlights New Clinical Study from - GlobeNewswire
Breakthrough Study: STRATA's XTRAC Laser Outperforms Competitors in Treating Skin Conditions - Stock Titan
VYNE Therapeutics to Participate in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference - The Manila Times
STRATA Skin Sciences (SSKN) Projected to Post Earnings on Wednesday - Defense World
Canada's new leader announces $4.2 billion Australian radar purchase on visit to Arctic Circle - The Globe and Mail
Hair Removal Devices Market Edition 2025: Global Industry Size - openPR
Hogs Close Higher in the Front Months on Friday - The Globe and Mail
Strata Skin Sciences Inc Stock (SSKN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Strata Skin Sciences Inc Stock (SSKN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Accelmed Partners, L.P. | 10% Owner |
Jul 15 '24 |
Buy |
3.14 |
230,573 |
723,999 |
1,441,835 |
| Rafaeli Dolev | Chief Executive Officer |
Jul 15 '24 |
Buy |
3.14 |
19,100 |
59,974 |
143,156 |
0.11%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):